about
Horizon 2020 in Diabetic Kidney Disease: The Clinical Trial Pipeline for Add-On Therapies on Top of Renin Angiotensin System BlockadeT Helper 17/Regulatory T Cell Balance and Experimental Models of Peritoneal Dialysis-Induced DamageTWEAK promotes peritoneal inflammationAngiotensin II contributes to renal fibrosis independently of Notch pathway activationSystemic infusion of angiotensin II into normal rats activates nuclear factor-kappaB and AP-1 in the kidney: role of AT(1) and AT(2) receptorsAngiotensin II Moderately Decreases Plasmodium Infection and Experimental Cerebral Malaria in MiceAngiotensin-(1-7) and the g protein-coupled receptor MAS are key players in renal inflammation2017 update on the relationship between diabetes and colorectal cancer: epidemiology, potential molecular mechanisms and therapeutic implicationsTNF superfamily: a growing saga of kidney injury modulators.BASP1 promotes apoptosis in diabetic nephropathy.Tubular overexpression of gremlin induces renal damage susceptibility in mice.Proinflammatory actions of angiotensins.Paricalcitol reduces peritoneal fibrosis in mice through the activation of regulatory T cells and reduction in IL-17 productionAngiotensin II and renal fibrosis.Role of the renin-angiotensin system in vascular diseases: expanding the field.A polymeric nanomedicine diminishes inflammatory events in renal tubular cellsSoluble co-signaling molecules predict long-term graft outcome in kidney-transplanted patientsOsteoprotegerin in exosome-like vesicles from human cultured tubular cells and urineMolecular mechanisms of angiotensin II-induced vascular injury.Inflammation and angiotensin II.Angiotensin II increases connective tissue growth factor in the kidney.Tweak induces proliferation in renal tubular epithelium: a role in uninephrectomy induced renal hyperplasiaTargeting of Gamma-Glutamyl-Cysteine Ligase by miR-433 Reduces Glutathione Biosynthesis and Promotes TGF-β-Dependent Fibrogenesis.Albumin-induced apoptosis of tubular cells is modulated by BASP1.Renal and vascular hypertension-induced inflammation: role of angiotensin II.TGF-beta signaling in vascular fibrosis.Angiotensin receptors and β-catenin regulate brain endothelial integrity in malaria.Unilateral ureteral obstruction: beyond obstruction.Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) and kidney disease.Endothelin-1, via ETA receptor and independently of transforming growth factor-beta, increases the connective tissue growth factor in vascular smooth muscle cells.Suppressors of cytokine signaling regulate angiotensin II-activated Janus kinase-signal transducers and activators of transcription pathway in renal cells.Designing drugs that combat kidney damage.BET Proteins: An Approach to Future Therapies in Transplantation.Atrasentan for the treatment of diabetic nephropathy.Up-regulation of the kinin B2 receptor pathway modulates the TGF-β/Smad signaling cascade to reduce renal fibrosis induced by albumin.Targeting inflammation in diabetic kidney disease: early clinical trials.Gremlin regulates renal inflammation via the vascular endothelial growth factor receptor 2 pathway.TNF-related weak inducer of apoptosis (TWEAK) regulates junctional proteins in tubular epithelial cells via canonical NF-κB pathway and ERK activation.High concentration of branched-chain amino acids promotes oxidative stress, inflammation and migration of human peripheral blood mononuclear cells via mTORC1 activation.GSK3, snail, and adhesion molecule regulation by cyclosporine A in renal tubular cells.
P50
Q26799443-B9F72228-D9AF-472D-9B55-B82961B907C6Q27002418-622F4965-81A4-4E60-827C-1218427FEA3BQ27318227-BC4B9F73-BC35-49FC-9616-FA3AE4F830AAQ27334791-0F9BF27D-9816-431D-B0F0-061CCF25A8F5Q28364369-A2A326DB-3242-4661-AFFE-31E986FA8128Q28548078-D93D83A4-6A91-4B0D-8D11-920D00D223AFQ28584967-E04423AA-2CB0-4347-8D7E-29B9BB7587B1Q30239808-4B6FF3DB-9510-4B8D-A99A-9184225E2C4BQ30479123-DD49A21A-FF8F-455E-9973-A7D7629F03F8Q33748559-3141E509-3F66-45A0-8C1E-889315BAFC9EQ33921130-7F23CF20-F066-496C-A26E-44B776F3AAA0Q34244757-7F7FE4E6-A173-4057-8DE5-052B0078616AQ34287169-94B832C5-3E07-4444-9FAA-41F3635B92B5Q34376512-D246FAC7-288C-4810-AE45-52CC6AB15FFBQ34467429-44E71CA3-1BFC-4C77-9C54-252AC17BB6B8Q34542058-BBBA864D-EE76-478C-B0BB-3ABAA9822934Q34639457-DA5593FB-7C58-443C-BD06-472AE7949BEAQ34994210-ED60CA1D-A008-4D44-87FF-F25FA2042D19Q35046512-64896D84-7D7D-424E-A0A3-74C5EB932D92Q35099157-BC8E58E4-5FE4-482D-8112-77FB2A5FAE7BQ35843514-1196F7CB-9FA4-44F9-9BA5-94F46D4FCCFBQ35893298-D8DC00D4-E8EC-4A9D-9FD5-E1B4AC78CF1AQ36311399-DED57E58-C900-441C-8F39-BAB0785A47C9Q36347210-C301FD28-D4A3-4223-A8E5-BDA1C05EF89AQ36398041-E7B75552-6FA7-45D7-ADE6-4200FAAACEBCQ36765987-000689BF-27C0-4A45-B138-DA53106C44A8Q37395730-6FA3F24B-0170-48E4-BA6C-8FDAA12B5CC3Q38144939-53A0696C-8C8B-46D2-82BC-867165318C1AQ38164489-1ED7603D-CF92-4B16-84EB-8B2404A47951Q38324521-AD57B1FD-F7A4-418E-8016-DDEE778BE096Q38328018-C63B957E-3D34-40C4-92FC-48AA4A1A95D9Q38404587-1CB9151E-D195-4E1D-9970-3AA9E93B5AF5Q38760291-49693E46-A492-460F-8488-38BD2963C2C0Q38806647-5FAF6320-F823-4F30-85CF-A19472F1011DQ38845046-1A3EB776-620D-498E-820A-2ECD7859E29CQ38857166-988A103B-D54B-483B-9621-4789EF2EEC74Q38895003-0B79175B-7A6A-4BA6-B69B-EBAFB46BEEBEQ38925875-708290D9-744C-4577-BCA4-9856F64F3D6AQ39019535-9DFCB9D7-AF4C-4A83-AA45-53DAE4FCEEBEQ39380020-E46D0C33-305A-48C7-8BDB-1B7C3DFB0457
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Marta Ruiz Ortega
@ast
Marta Ruiz Ortega
@en
Marta Ruiz Ortega
@es
Marta Ruiz Ortega
@nl
type
label
Marta Ruiz Ortega
@ast
Marta Ruiz Ortega
@en
Marta Ruiz Ortega
@es
Marta Ruiz Ortega
@nl
prefLabel
Marta Ruiz Ortega
@ast
Marta Ruiz Ortega
@en
Marta Ruiz Ortega
@es
Marta Ruiz Ortega
@nl
P106
P21
P31
P496
0000-0002-1495-6535